{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:04:20Z","timestamp":1792173860885,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.ijrobp.2006.11.060","type":"journal-article","created":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T16:07:33Z","timestamp":1177085253000},"page":"13-23","source":"Crossref","is-referenced-by-count":573,"title":["Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium"],"prefix":"10.1016","volume":"68","author":[{"given":"Andrew","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subir","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"McEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Nutting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Al","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Espat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky A.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Coldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.11.060_bib1","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib2","first-page":"1067","article-title":"The blood supply of experimental liver metastases. I: The distribution of hepatic artery and portal vein blood to \u201csmall\u201d and \u201clarge\u201d tumors","volume":"66","author":"Ackerman","year":"1970","journal-title":"Surgery"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib3","first-page":"156","article-title":"Comparison of two 90Yttrium microsphere agents for hepatic artery brachytherapy","volume":"1","author":"Kennedy","year":"2003","journal-title":"Proceedings of the 4th International Congress on Anti-Cancer Treatment"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2004.11.037","article-title":"Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment","volume":"22","author":"Grothey","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib6","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","article-title":"Angiographic considerations in patients undergoing liver-directed therapy","volume":"16","author":"Liu","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/radiology.187.1.8451398","article-title":"Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings","volume":"187","author":"Marn","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.RVI.0000161142.12822.66","article-title":"Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results","volume":"16","author":"Murthy","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib10","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/01.RVI.0000179815.44868.66","article-title":"90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135\u2013150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging","volume":"16","author":"Lewandowski","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","article-title":"Pathologic response and microdosimetry of 90Y microspheres in man: Review of four explanted whole livers","volume":"60","author":"Kennedy","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience","volume":"65","author":"Kennedy","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","article-title":"Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival","volume":"16","author":"Salem","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1445-2197.1992.tb00006.x","article-title":"Regression of liver metastases following treatment with yttrium-90 microspheres","volume":"62","author":"Gray","year":"1992","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib15","first-page":"333","article-title":"Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases","volume":"48","author":"Stubbs","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bjc.1994.436","article-title":"Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase I and II study","volume":"70","author":"Lau","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0360-3016(97)00818-3","article-title":"Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres","volume":"40","author":"Lau","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib18","first-page":"S113","article-title":"Feasibility of treatment of hepatic tumors utilizing embolization with yttrium-90 glass microspheres","volume":"12","author":"Coldwell","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib19","first-page":"468","article-title":"Outpatient hepatic artery brachytherapy for primary and secondary hepatic malignancies","volume":"221P","author":"Kennedy","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0959-8049(01)81560-4","article-title":"Preliminary results of outpatient hepatic artery brachytherapy for colorectal hepatic metastases","volume":"37","author":"Kennedy","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib21","first-page":"S2","article-title":"Technical aspects of TheraSphere (TS) infusion","volume":"13","author":"Murthy","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib22","first-page":"1038","article-title":"TheraSphere (TS) at 143 Gy median dose for mixed hepatic cancers: Feasibility and toxicities","volume":"260a","author":"Van Echo","year":"2001","journal-title":"Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","article-title":"Randomised phase II trial of SIR-spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer","volume":"88","author":"Van Hazel","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib25","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.RVI.0000142602.79459.90","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: A risk-stratification analysis","volume":"16","author":"Goin","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib27","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1002\/lt.20036","article-title":"Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients","volume":"10","author":"Carr","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib28","first-page":"1673","article-title":"Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres","volume":"41","author":"Dancey","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib29","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","article-title":"Yttrium-90 microspheres for the treatment of hepatocellular carcinoma","volume":"127","author":"Geschwind","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/000313480407001103","article-title":"Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma","volume":"70","author":"Liu","year":"2004","journal-title":"Am Surg"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pon.725","article-title":"Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere)","volume":"13","author":"Steel","year":"2004","journal-title":"Psychooncology"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.gassur.2005.06.019","article-title":"Successful embolization of hepatocellular carcinoma with yttrium-90 glass microspheres prior to liver transplantation","volume":"10","author":"Kim","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/lt.20514","article-title":"Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case report","volume":"11","author":"Kulik","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib35","first-page":"49","article-title":"Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: Trans-catheter arterial chemo-embolization versus yttrium-90 glass microspheres","volume":"3","author":"Goin","year":"2004","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.RVI.00001142592.89564.F9","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities","volume":"16","author":"Goin","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib38","first-page":"200","article-title":"Radiation hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib39","first-page":"351","article-title":"Extra-hepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver","volume":"35","author":"Thamboo","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.RVI.0000177063.92678.21","article-title":"The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma","volume":"16","author":"Rhee","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2006.11.060_bib41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0360-3016(95)00039-3","article-title":"Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors","volume":"33","author":"Leung","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301607000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301607000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T14:47:15Z","timestamp":1683816435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301607000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0360301607000971"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.11.060","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}